You have searched for "trial results"
Showing 1-10 of 276
Coronavirus: fuller picture of Chinese vaccine data but WHO group finds figures lacking for over 60s
Advisory group assesses vaccines by Sinopharm and Sinovac Biotech ahead of their evaluation for WHO emergency authorisationConcern that not enough data is available about effects of these vaccines on elderly and medically vulnerable patients
BERLIN (Reuters) - BioNTech expects results by September from trials testing the COVID-19 vaccine that it and Pfizer have developed in babies as young as six months old, German magazine Spiegel cited the company's CEO as saying.
These three Covid-19 vaccines utilise inactivated virus technology with an incorporated SARS-CoV-2 viral gene to varying levels of effectiveness.
VIENNA (Reuters) - Austria will only use Russia's Sputnik V coronavirus vaccine once the European Medicines Agency has approved it, Chancellor Sebastian Kurz said on Monday, amid growing public frustration with the pace of COVID-19 vaccinations.
(Reuters) - Australia and the Philippines limited use of AstraZeneca's COVID-19 vaccine on Thursday, while the African Union dropped plans to buy the shot amid global shortages, dealing further blows to the company's hopes to deliver a vaccine for the world.
JAKARTA (The Jakarta Post/ANN): International airports in Bandung, Surabaya, Yogyakarta and Palembang plan to start offering the GeNose coronavirus breathalyser test to domestic passengers on April 1 in a bid to speed up health checks, despite the current mobility restrictions in Indonesia.
VIENNA (Reuters) - Austria is in talks with Russia to buy a million doses of its Sputnik V coronavirus vaccine, which has yet to be approved by the European Medicines Agency, Chancellor Sebastian Kurz's office said on Tuesday.
The emergence of SARS-CoV-2 virus variants that seem able to evade current vaccines and spread more easily are a cause for concern.
The first batch of Covid-19 vaccines completed locally was manufactured without a hitch, thanks to intensive preparations and investments.
LONDON/TAIPEI (Reuters) - AstraZeneca's COVID-19 vaccine performed better than expected in a major late-stage trial, paving the way for its potential emergency authorization in the United States and boosting confidence in the shot after setbacks in Europe.